Anti–vascular endothelial growth factor (VEGF) medications have been a mainstay of treatment for wet age-related macular degeneration (wet AMD) for 20 years — and for good reason. The medication has dramatically improved outcomes for people with the eye condition. “Before we had anti-VEGF treatments, we [used] surgery, laser, and other medications to treat …
Read More »